Femasys secures distribution partnerships for commercialization of fembloc® in spain

-- company taps first eu distributors, comercial medico quirurigca, sa and durgalab, as the first globally to be granted rights to commercialize fembloc® -- atlanta, march 18, 2025 (globe newswire) -- femasys inc., (nasdaq: femy), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, announces the company has secured strategic distribution partnerships for fembloc® in spain. comercial medico quirurigca, sa (cmq) will expand its commercial portfolio to include fembloc, alongside other femasys products in northern spain, while durgalab will handle distribution in the southern region.
FEMY Ratings Summary
FEMY Quant Ranking